Skip to search formSkip to main contentSkip to account menu

KW 2228

Known as: KW-2228 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
A randomized controlled study of patients with multiple myeloma was performed to evaluate the efficacy and safety of recombinant… 
1992
1992
An enzyme-linked immunosorbent assay (ELISA) for marograstim (KW-2228) was established. This ELISA proved to be highly sensitive… 
1992
1992
The tissue levels of KW-2228 in rats were determined by the ELISA after intravenous or subcutaneous administration. 1. At 5 min… 
1992
1992
A modified recombinant human granulocyte colony-stimulating factor (rhG-CSF), KW-2228, has some excellent properties such as high… 
1991
1991
Pharmacokinetics and hematopoietic effects of KW-2228 and recombinant human granulocyte colony stimulating factor (rhG-CSF) in… 
1991
1991
Using cynomolgus monkeys, we studied the hematopoietic effect and antigenicity of the human granulocyte colony-stimulating factor… 
1990
1990
Human granulocyte colony-stimulating factor (G-CSF) rapidly loses the biological activity and the receptor binding capacity…